Healthcare & Life Sciences
Delix Therapeutics
United Stateswww.delixtherapeutics.com/
Delix Therapeutics is a series a startup based in United States. 1 investor tracked.
Activeseries-a
series-a
Stage
2018
Founded
3
Investors
About Delix Therapeutics
Based in the United States, Delix Therapeutics is a startup founded in 2018. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Delix Therapeutics develops novel neuroplasticity-promoting therapeutics, known as neuroplastogens, for central nervous system diseases such as depression and PTSD. Their compounds aim to induce rapid and long-lasting structural and functional changes in neural circuits without hallucinogenic effects.
Explore Delix Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.